Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001493152-25-017262·Denbaars Steven
Schedule 13D ownership disclosure
Palomino Laboratories Inc.
Common Stock, par value $0.0001 per share · CUSIP: 909233108
Event date: 2025-09-29
- Filing-level shares
- 1,750,000.00
- Percent of class
- 9.4%
- Steven DenBaarsReported CIK 0001700533
Shares: 1,750,000.00 · Class: 9.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-017262
- Form type
- SCHEDULE 13D
- Filer
- Denbaars Steven
- CIK
- CIK 1700533
- Filed
- Oct 07, 2025
- Reporting period
- Sep 29, 2025
- Description
- Schedule 13D beneficial ownership